Where Are the Best Cannabis Investment Opportunities in New York?
Opportunities that Hinge on New York Marijuana Legalization
At present, the medical cannabis program in New York is expanding steadily. Between January and December 2019, the number of medical marijuana patients in the state rose from 88 thousand to 111 thousand. However, compared to other states, uptake is low. In spite of perks like home delivery, less than 1% of New York residents are medical marijuana patients, while 6.3% of Oklahomans have registered. Given that New York’s qualifying condition list is robust, and that in 2017 New Yorkers smoked more cannabis than any other city in the world, an explanation for this low uptake may be that the majority of cannabis-consuming New York state residents are sourcing their cannabis products from the black market. The tax revenue lost from this huge market is itself reason for the state to legalize cannabis sales and profit from the legal market.
Cannabis Growth Fund allows investors to take a broad-spread approach to cannabis investment. Our actively managed mutual fund focuses primarily on companies related to the cannabis industry. We are an alternative to spending hours poring over industry periodicals for which individual stocks to buy. If you’re interested in investing with us, you can enquire through our website.
Foothill Capital Management is the advisor of the Cannabis Growth Fund and is not affiliated with the distributor.
OF SPECIAL NOTE
Statements, estimates and forecasts are subject to significant legal, business, economic, and competitive uncertainties, including competition, limited access to bank services, litigation, enforcement actions, and the receipt of government authorizations. This includes differences in, among other things, laws, regulations and guidelines relating to the manufacture, transportation, and storage of cannabis, and the conduct of operations, which vary among the U.S. federal government, various states, and foreign jurisdictions. There can no assurance that such estimates and/or forecasts will be realized, and these are not indicative of future investment performance. Historical data is not indicative of future performance.
Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained from 888.885.0588 or at https://www.cannabisgrowthfunds.com/. Please read the prospectus carefully before you invest.
Foreign investing involves social and political instability, market illiquidity, exchange-rate fluctuation, high volatility and limited regulation risks. Emerging markets involve different and greater risks, as they are smaller, less liquid and more volatile than more developed countries. Investments made in small, mid-capitalization and micro-capitalization companies may be more volatile and less liquid due to limited resources or product lines and more sensitive to economic factors. Fund investments will be concentrated in an industry or group of industries, and the value of Fund shares may rise and fall more than more diversified funds. Purchasing and writing put and call options entails greater than ordinary investment risks. Options ownership involves the payment of premiums, which may negatively impact Fund performance. Please see the prospectus for details of these and other risks. Distributed by IMST Distributors, LLC.